6533b825fe1ef96bd12833cd

RESEARCH PRODUCT

Regio- and Stereoselective Synthesis of Spiropyrrolizidines and Piperazines through Azomethine Ylide Cycloaddition Reaction.

Armand SolderaSarra BoudrigaMoheddine AskriChristopher GolzMarek M. KubickiSaoussen HaddadMichael KnorrCarsten StrohmannFrançois PorzioYoann Rousselin

subject

IsatinThiosemicarbazonesStereochemistryAzomethine ylideStereoisomerism010402 general chemistry01 natural sciencesPiperazineschemistry.chemical_compoundX-Ray DiffractionStructural isomerSpiro CompoundsComputingMilieux_MISCELLANEOUSPyrrolizidine AlkaloidsCycloaddition Reaction010405 organic chemistryHydrogen bondIsatinOrganic ChemistryStereoisomerismCycloaddition0104 chemical sciencesKineticschemistryCyclizationQuantum TheoryStereoselectivity[PHYS.ASTR]Physics [physics]/Astrophysics [astro-ph]IsomerizationAzo Compounds

description

A series of original spiropyrrolizidine derivatives has been prepared by a one-pot three-component [3 + 2] cycloaddition reaction of (E)-3-arylidene-1-phenyl-pyrrolidine-2,5-diones, l-proline, and the cyclic ketones 1H-indole-2,3-dione (isatin), indenoquinoxaline-11-one and acenaphthenequinone. We disclose an unprecedented isomerization of some spiroadducts leading to a new family of spirooxindolepyrrolizidines. Furthermore, these cycloadducts underwent retro-1,3-dipolar cycloaddition yielding unexpected regioisomers. Upon treatment of the dipolarophiles with in situ generated azomethine ylides from l-proline or acenaphthenequinone, formation of spiroadducts and unusual polycyclic fused piperazines through a stepwise [3 + 3] cycloaddition pathway is observed. The stereochemistry of these N-heterocycles has been confirmed by several X-ray diffraction studies. Some of these compounds exhibit extensive hydrogen bonding in the crystalline state. To enlighten the observed regio- and stereoselectivity of the [3 + 2] cycloaddition, calculations using the DFT approach at the B3LYP/6-31G(d,p) level were carried out. It was found that this reaction is under kinetic control.

10.1021/acs.joc.5b01399https://pubmed.ncbi.nlm.nih.gov/26291879